Puneet Souda
Stock Analyst at Leerink Partners
(1.92)
# 1,653
Out of 4,479 analysts
176
Total ratings
44.26%
Success rate
-2.09%
Average return
Main Sectors:
25 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Upgrades: Outperform | $25 → $35 | $24.76 | +41.36% | 6 | May 8, 2024 | |
| CYRX Cryoport | Downgrades: Market Perform | $30 → $10 | $6.18 | +61.81% | 5 | Jul 13, 2023 | |
| TMO Thermo Fisher | Maintains: Outperform | $630 | $533.93 | +17.99% | 17 | Jul 6, 2023 | |
| CSTL Castle Biosciences | Maintains: Outperform | $50 → $35 | $21.26 | +64.63% | 7 | Jun 5, 2023 | |
| A Agilent Technologies | Maintains: Outperform | $170 → $145 | $125.78 | +15.28% | 18 | May 24, 2023 | |
| WAT Waters | Maintains: Market Perform | $300 | $284.49 | +5.45% | 13 | May 9, 2023 | |
| DHR Danaher | Initiates: Outperform | $300 | $240.41 | +24.79% | 1 | May 1, 2023 | |
| ILMN Illumina | Maintains: Outperform | $249 → $250 | $105.51 | +136.94% | 13 | Feb 8, 2023 | |
| TECH Bio-Techne | Maintains: Outperform | $125 → $110 | $71.24 | +54.41% | 6 | Feb 3, 2023 | |
| HOLX Hologic | Maintains: Outperform | $90 → $93 | $73.53 | +26.48% | 5 | Feb 2, 2023 | |
| EXAS Exact Sciences | Maintains: Outperform | $70 → $75 | $43.17 | +73.73% | 16 | Jan 12, 2023 | |
| RGEN Repligen | Maintains: Outperform | $230 → $200 | $120.14 | +66.47% | 7 | Jan 6, 2023 | |
| MASS 908 Devices | Maintains: Outperform | $25 → $20 | $4.73 | +322.83% | 5 | Jan 6, 2023 | |
| ABCL AbCellera Biologics | Maintains: Outperform | $20 → $18 | $2.77 | +549.82% | 6 | Jan 6, 2023 | |
| OABI OmniAb | Initiates: Outperform | $6 | $3.67 | +63.49% | 1 | Nov 29, 2022 | |
| TWST Twist Bioscience | Maintains: Market Perform | $45 → $30 | $47.32 | -36.60% | 6 | Nov 21, 2022 | |
| OLK Olink Holding AB (publ) | Maintains: Outperform | $25 → $27 | $25.73 | +4.94% | 4 | Nov 15, 2022 | |
| QTRX Quanterix | Maintains: Market Perform | $12 → $15 | $12.72 | +17.92% | 7 | Nov 9, 2022 | |
| NEO NeoGenomics | Maintains: Outperform | $12 → $15 | $13.73 | +9.25% | 6 | Nov 9, 2022 | |
| VCYT Veracyte | Maintains: Outperform | $30 → $35 | $21.26 | +64.63% | 9 | Nov 3, 2022 | |
| CNTG Centogene | Maintains: Outperform | $10 → $6 | $0.41 | +1,363.41% | 1 | Jul 18, 2022 | |
| BRKR Bruker | Maintains: Outperform | $85 → $87 | $61.64 | +41.14% | 6 | May 5, 2022 | |
| GH Guardant Health | Maintains: Outperform | $170 → $140 | $28.87 | +384.93% | 3 | Feb 24, 2022 | |
| NTRA Natera | Maintains: Outperform | n/a | $110.70 | - | 3 | Jun 22, 2021 | |
| TTOO T2 Biosystems | Maintains: Outperform | $20,000 → $15,000 | $5.08 | +295,175.59% | 5 | Jan 27, 2021 |
Myriad Genetics
May 8, 2024
Upgrades: Outperform
Price Target: $25 → $35
Current: $24.76
Upside: +41.36%
Cryoport
Jul 13, 2023
Downgrades: Market Perform
Price Target: $30 → $10
Current: $6.18
Upside: +61.81%
Thermo Fisher
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $533.93
Upside: +17.99%
Castle Biosciences
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $21.26
Upside: +64.63%
Agilent Technologies
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $125.78
Upside: +15.28%
Waters
May 9, 2023
Maintains: Market Perform
Price Target: $300
Current: $284.49
Upside: +5.45%
Danaher
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $240.41
Upside: +24.79%
Illumina
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $105.51
Upside: +136.94%
Bio-Techne
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $71.24
Upside: +54.41%
Hologic
Feb 2, 2023
Maintains: Outperform
Price Target: $90 → $93
Current: $73.53
Upside: +26.48%
Exact Sciences
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $43.17
Upside: +73.73%
Repligen
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $120.14
Upside: +66.47%
908 Devices
Jan 6, 2023
Maintains: Outperform
Price Target: $25 → $20
Current: $4.73
Upside: +322.83%
AbCellera Biologics
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $2.77
Upside: +549.82%
OmniAb
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $3.67
Upside: +63.49%
Twist Bioscience
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $47.32
Upside: -36.60%
Olink Holding AB (publ)
Nov 15, 2022
Maintains: Outperform
Price Target: $25 → $27
Current: $25.73
Upside: +4.94%
Quanterix
Nov 9, 2022
Maintains: Market Perform
Price Target: $12 → $15
Current: $12.72
Upside: +17.92%
NeoGenomics
Nov 9, 2022
Maintains: Outperform
Price Target: $12 → $15
Current: $13.73
Upside: +9.25%
Veracyte
Nov 3, 2022
Maintains: Outperform
Price Target: $30 → $35
Current: $21.26
Upside: +64.63%
Centogene
Jul 18, 2022
Maintains: Outperform
Price Target: $10 → $6
Current: $0.41
Upside: +1,363.41%
Bruker
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $61.64
Upside: +41.14%
Guardant Health
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $28.87
Upside: +384.93%
Natera
Jun 22, 2021
Maintains: Outperform
Price Target: n/a
Current: $110.70
Upside: -
T2 Biosystems
Jan 27, 2021
Maintains: Outperform
Price Target: $20,000 → $15,000
Current: $5.08
Upside: +295,175.59%